| scholarly article | Q13442814 |
| P2093 | author name string | Yan Zhao | |
| Tao Tao | |||
| Jiaxin Deng | |||
| Zhongya Chen | |||
| P2860 | cites work | Non-peptide fibrinogen receptor antagonists. 2. Optimization of a tyrosine template as a mimic for Arg-Gly-Asp | Q72122283 |
| Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies | Q72607211 | ||
| Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases | Q72927459 | ||
| Non-peptide RGD surrogates which mimic a Gly-Asp beta-turn: potent antagonists of platelet glycoprotein IIb-IIIa | Q73477705 | ||
| Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system - The concept of tissue specificity | Q73850374 | ||
| Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer | Q77925484 | ||
| A tumor vasculature targeted liposome delivery system for combretastatin A4: design, characterization, and in vitro evaluation | Q79779370 | ||
| Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand | Q24292425 | ||
| Integrin ligands at a glance | Q24600618 | ||
| Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential | Q24657256 | ||
| Structural basis of collagen recognition by integrin alpha2beta1 | Q27622310 | ||
| Structures of the alpha L I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation | Q27640304 | ||
| RGD and other recognition sequences for integrins | Q29616331 | ||
| The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting | Q34268743 | ||
| Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer | Q34302904 | ||
| Liposomes: applications in medicine | Q34320703 | ||
| Developments in liposomal drug delivery systems | Q34452675 | ||
| Liposome-based approaches to overcome anticancer drug resistance | Q35595419 | ||
| Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates | Q35749892 | ||
| Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes | Q36713632 | ||
| Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time | Q36800814 | ||
| Efficacy of immunoliposomes on cancer models in a cell-surface-antigen-density-dependent manner | Q38602679 | ||
| Solid-phase peptide synthesis: a silver anniversary report. | Q39695676 | ||
| Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody | Q40502849 | ||
| Use of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity. | Q40740174 | ||
| Targeting Stealth liposomes in a murine model of human small cell lung cancer. | Q40767106 | ||
| Preparation of long-circulating immunoliposomes containing adriamycin by a novel method to coat immunoliposomes with poly(ethylene glycol) | Q41310398 | ||
| Conformational preferences in a benzodiazepine series of potent nonpeptide fibrinogen receptor antagonists | Q42594498 | ||
| Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes | Q44239742 | ||
| Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma | Q45029233 | ||
| Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells. | Q45137105 | ||
| Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic | Q46672743 | ||
| Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts | Q47220999 | ||
| Liposome immunoassay (LIA) with antigen-coupled liposomes containing alkaline phosphatase | Q70590281 | ||
| Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa recepto | Q70771276 | ||
| Determination of the concentration of adriamycin and its metabolites in the serum and tissues of Ehrlich carcinoma-bearing mice by high-performance liquid chromatography | Q71365016 | ||
| Targeted delivery of doxorubicin via sterically stabilized immunoliposomes: pharmacokinetics and biodistribution in tumor-bearing mice | Q71499844 | ||
| Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures | Q71561921 | ||
| Non-peptide glycoprotein IIb/IIIa antagonists. 11. Design and in vivo evaluation of 3,4-dihydro-1 (1H)-isoquinolinone-based antagonists and ethyl ester prodrugs | Q71777007 | ||
| Potent in Vitro and in Vivo Inhibitors of Platelet Aggregation Based Upon the Arg-Gly-Asp Sequence of Fibrinogen. (Aminobenzamidino)succinyl (ABAS) Series of Orally Active Fibrinogen Receptor Antagonists | Q71871216 | ||
| Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft | Q72018692 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacokinetics | Q323936 |
| drug delivery | Q1392806 | ||
| P304 | page(s) | 3803-3811 | |
| P577 | publication date | 2012-07-18 | |
| P1433 | published in | International Journal of Nanomedicine | Q6051502 |
| P1476 | title | Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats | |
| P478 | volume | 7 |
| Q36467648 | A new target ligand Ser-Glu for PEPT1-overexpressing cancer imaging |
| Q34692050 | A novel small peptide as an epidermal growth factor receptor targeting ligand for nanodelivery in vitro |
| Q60309365 | A peptide-CpG-DNA-liposome complex vaccine targeting TM4SF5 suppresses growth of pancreatic cancer in a mouse allograft model |
| Q38564219 | Anti-angiogenic nanotherapy via active targeting systems to tumors and adipose tissue vasculature. |
| Q38126543 | Current trends in the use of liposomes for tumor targeting |
| Q37705643 | Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects |
| Q36879532 | Detection and imaging of aggressive cancer cells using an epidermal growth factor receptor (EGFR)-targeted filamentous plant virus-based nanoparticle |
| Q29048586 | Evaluation of the use of therapeutic peptides for cancer treatment |
| Q28541327 | Improved efficacy and reduced toxicity of doxorubicin encapsulated in sulfatide-containing nanoliposome in a glioma model |
| Q89638591 | Nanoparticle-based Cell Trackers for Biomedical Applications |
| Q39036547 | Novel tumor-targeting, self-assembling peptide nanofiber as a carrier for effective curcumin delivery |
| Q61813035 | Peptide-Based Drug-Delivery Systems in Biotechnological Applications: Recent Advances and Perspectives |
| Q91952374 | Pharmacokinetic stability of macrocyclic peptide triazole HIV-1 inactivators alone and in liposomes |
| Q53496588 | Pyrrolysine-inspired protein cyclization. |
| Q35970627 | RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancer |
| Q39086982 | Recombinant lipoproteins reinforce cytotoxicity of doxorubicin to hepatocellular carcinoma |
| Q38502588 | Review peptide-targeted liposomes for selective drug delivery: Advantages and problematic issues |
| Q47190264 | Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review |
| Q37027655 | The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation |
| Q38176391 | The interaction of nanoparticles with plasma proteins and the consequent influence on nanoparticles behavior |
| Q35027207 | Tunable ultrasmall visible-to-extended near-infrared emitting silver sulfide quantum dots for integrin-targeted cancer imaging |
| Q58493109 | Uptake and Intracellular Fate of Peptide Surface-Functionalized Silica Hybrid Magnetic Nanoparticles In Vitro |
| Q41383344 | [Pyr1]-Apelin-13 delivery via nano-liposomal encapsulation attenuates pressure overload-induced cardiac dysfunction. |
Search more.